A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...

The escalating bird flu crisis is ravaging the nation's egg supply, and that shortage has hit Arizona along with the rest of ...

Most of the bird flu cases reported so far in the U.S. have belonged to an influenza subtype known as HPAI H5N1. The newly ...

Last Friday, HHS announced it will provide approximately $590 million to Moderna to accelerate the development of mRNA-based ...

Health officials urged people to identify avian flu symptoms early and properly cook chicken and eggs to limit risk of ...

This latest financial support comes on top of the $176 million BARDA gave Moderna last summer. “Avian flu variants have proven to be particularly unpredictable and dangerous to humans in the past.